NO20064986L - Krystallin Pyrazolderivater - Google Patents
Krystallin PyrazolderivaterInfo
- Publication number
- NO20064986L NO20064986L NO20064986A NO20064986A NO20064986L NO 20064986 L NO20064986 L NO 20064986L NO 20064986 A NO20064986 A NO 20064986A NO 20064986 A NO20064986 A NO 20064986A NO 20064986 L NO20064986 L NO 20064986L
- Authority
- NO
- Norway
- Prior art keywords
- pyrazole derivatives
- crystalline
- crystalline pyrazole
- benzenesulfonamide
- pyrazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W16/00—Network planning, e.g. coverage or traffic planning tools; Network deployment, e.g. resource partitioning or cells structures
- H04W16/18—Network planning tools
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W24/00—Supervisory, monitoring or testing arrangements
- H04W24/02—Arrangements for optimising operational condition
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Signal Processing (AREA)
- Computer Networks & Wireless Communication (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Foreliggende oppfinnelse krystallformer av 4-[5-(4-fluorfenyl)-3-(trifluormetyl)-lH-pyrazol-l-yl]-benzensulfonamid og fremgangsmåter for fremstilling, mellomomdanning og isolering av slike krystaller.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55846904P | 2004-04-01 | 2004-04-01 | |
| PCT/IB2005/000735 WO2005095349A1 (en) | 2004-04-01 | 2005-03-21 | Crystalline pyrazole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20064986L true NO20064986L (no) | 2006-12-21 |
Family
ID=34961629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20064986A NO20064986L (no) | 2004-04-01 | 2006-10-31 | Krystallin Pyrazolderivater |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7652149B2 (no) |
| EP (1) | EP1742922B1 (no) |
| JP (1) | JP4177883B2 (no) |
| KR (1) | KR100820511B1 (no) |
| CN (1) | CN1938276B (no) |
| AR (1) | AR048449A1 (no) |
| AU (1) | AU2005227745C1 (no) |
| BR (1) | BRPI0509506A8 (no) |
| CA (1) | CA2562104C (no) |
| DK (1) | DK1742922T3 (no) |
| EA (1) | EA008697B1 (no) |
| ES (1) | ES2565409T3 (no) |
| HK (1) | HK1099755A1 (no) |
| HU (1) | HUE028811T2 (no) |
| IL (1) | IL177711A0 (no) |
| MA (1) | MA28494B1 (no) |
| NO (1) | NO20064986L (no) |
| NZ (1) | NZ550907A (no) |
| PL (1) | PL1742922T3 (no) |
| SI (1) | SI1742922T1 (no) |
| TN (1) | TNSN06313A1 (no) |
| TW (1) | TW200536816A (no) |
| UA (1) | UA84455C2 (no) |
| WO (1) | WO2005095349A1 (no) |
| ZA (1) | ZA200607154B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE028811T2 (en) * | 2004-04-01 | 2017-01-30 | Zoetis Services Llc | Crystalline pyrazole derivative |
| JP5396085B2 (ja) | 2005-12-14 | 2014-01-22 | マクテシム・ケミカル・ワークス・リミテツド | ５−アミノ−１−［２，６−ジクロロ−４−（トリフルオロメチル）フェニル］−４−［（トリフルオロメチル）スルフィニル］−１ｈ−ピラゾール−３−カルボニトリルの多形および非晶形 |
| KR101540122B1 (ko) | 2006-11-10 | 2015-07-28 | 바스프 에스이 | 피프로닐의 결정질 변형물 |
| NZ576524A (en) | 2006-11-10 | 2012-01-12 | Basf Se | Crystalline modification of fipronil |
| UA110598C2 (uk) | 2006-11-10 | 2016-01-25 | Басф Се | Спосіб одержання кристалічної модифікації фіпронілу |
| JP2017081860A (ja) * | 2015-10-29 | 2017-05-18 | 株式会社トクヤマ | セレコキシブの製造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE67187B1 (en) | 1990-06-15 | 1996-03-06 | Merck & Co Inc | A crystallization method to improve crystal structure and size |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US6492411B1 (en) * | 1993-11-30 | 2002-12-10 | G. D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| CA2234633A1 (en) | 1995-10-17 | 1997-04-24 | G.D. Searle & Co. | Method of detecting cyclooxygenase-2 |
| US6083986A (en) | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
| US6221153B1 (en) | 1998-06-09 | 2001-04-24 | Trevor Percival Castor | Method for producing large crystals of complex molecules |
| US6787154B2 (en) | 1998-10-20 | 2004-09-07 | Salvatore Albani | Artificial antigen presenting cells |
| SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| TR200001872A3 (tr) * | 2000-06-26 | 2002-01-21 | Fako Ilaclari A.S | 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem. |
| HUE028811T2 (en) * | 2004-04-01 | 2017-01-30 | Zoetis Services Llc | Crystalline pyrazole derivative |
-
2005
- 2005-03-21 HU HUE05708783A patent/HUE028811T2/en unknown
- 2005-03-21 ES ES05708783.5T patent/ES2565409T3/es active Active
- 2005-03-21 CN CN2005800098297A patent/CN1938276B/zh active Active
- 2005-03-21 EP EP05708783.5A patent/EP1742922B1/en active Active
- 2005-03-21 JP JP2007505649A patent/JP4177883B2/ja active Active
- 2005-03-21 WO PCT/IB2005/000735 patent/WO2005095349A1/en active Application Filing
- 2005-03-21 KR KR1020067020308A patent/KR100820511B1/ko not_active IP Right Cessation
- 2005-03-21 CA CA2562104A patent/CA2562104C/en active Active
- 2005-03-21 NZ NZ550907A patent/NZ550907A/en unknown
- 2005-03-21 EA EA200601601A patent/EA008697B1/ru not_active IP Right Cessation
- 2005-03-21 SI SI200532061A patent/SI1742922T1/sl unknown
- 2005-03-21 DK DK05708783.5T patent/DK1742922T3/en active
- 2005-03-21 PL PL05708783T patent/PL1742922T3/pl unknown
- 2005-03-21 UA UAA200610388A patent/UA84455C2/ru unknown
- 2005-03-21 AU AU2005227745A patent/AU2005227745C1/en active Active
- 2005-03-21 BR BRPI0509506A patent/BRPI0509506A8/pt not_active Application Discontinuation
- 2005-03-30 AR ARP050101229A patent/AR048449A1/es not_active Application Discontinuation
- 2005-03-31 TW TW094110251A patent/TW200536816A/zh unknown
- 2005-03-31 US US11/095,381 patent/US7652149B2/en active Active
-
2006
- 2006-08-27 IL IL177711A patent/IL177711A0/en unknown
- 2006-08-28 ZA ZA200607154A patent/ZA200607154B/en unknown
- 2006-09-29 TN TNP2006000313A patent/TNSN06313A1/fr unknown
- 2006-09-29 MA MA29353A patent/MA28494B1/fr unknown
- 2006-10-31 NO NO20064986A patent/NO20064986L/no unknown
-
2007
- 2007-05-29 HK HK07105647.9A patent/HK1099755A1/xx unknown
-
2009
- 2009-12-18 US US12/641,404 patent/US20100093820A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20064986L (no) | Krystallin Pyrazolderivater | |
| DK3724191T3 (da) | 5-(2-(2,5-difluorphenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazol[1,5-a]pyrimidinderivater og lignende forbindelser som trk-kinasehæmmere til cancerbehandling | |
| NO20072443L (no) | Fungicide aktive ingredienskombinasjoner | |
| NO20081631L (no) | Lav hygroskopisk Aripiprazol medikament forbindelse og fremgangsmate for fremstilling derav | |
| TW200616965A (en) | Synthesis of n2-(substituted arylmethyl)-3-(substituted phenyl)indazoles as novel anti-angiogenic agents | |
| DK1713475T3 (da) | 1,3,5-trisubstituerede 4,5-dihydro-1H-pyrazol-derivater med CB1-antagonistisk aktivitet | |
| ATE532781T1 (de) | 5-(acylamino)indazol-derivate als kinase- inhibitoren | |
| NO20053546D0 (no) | Triazolderivater som inhibitorer av 11-beta-hydroksysteroiddehydrogenase-1. | |
| WO2008058285A3 (en) | 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors | |
| WO2006034093A3 (en) | 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors | |
| NO20071073L (no) | Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer | |
| IN2014DN08578A (no) | ||
| EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
| PE20080545A1 (es) | Isoxazolinas insecticidas | |
| CA2471952A1 (en) | Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists | |
| WO2003076398A3 (en) | Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors | |
| NO20075384L (no) | Tiadiazolsubstituerte kumarinderivater og deres anvendelse som leukotrienbiosynteseinhibitorer. | |
| WO2008060476A3 (en) | Nitrogen-containing heterocyclic compounds and methods of use thereof | |
| EA200300067A1 (ru) | Кристаллическая форма целекоксиба | |
| EP4028393A4 (en) | 3,5-DISUBSTITUTED PYRAZOLE COMPOUNDS AS KINAS INHIBITORS AND THEIR USES | |
| WO2007069254A3 (en) | POLYMORPHS AND AMORPHOUS FORMS OF 5-AMINO-l-[2,6- DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-4- [(TRIFLUOROMETHYL)SULFINYL]-IH-PYRAZOLE-3-CARBONITRILE | |
| MX2023002890A (es) | Procesos e intermedios para la preparacion de (s)-5-amino-3-(4-((5-fluoro-2-metoxibenzamido)metil)fenil)-1-(1,1 ,1-trifluoropropan-2-il)-1h-pirazol-4-carboxamida. | |
| WO2010095024A3 (en) | An improved process for the preparation of celecoxib and purification process | |
| NO20052813L (no) | Celecoxib-promedikament | |
| WO2003047517A3 (en) | Novel-n-[4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa |